These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 15925496

  • 1. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND.
    Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
    [Abstract] [Full Text] [Related]

  • 2. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
    Grisaru S, Cano-Gauci D, Tee J, Filmus J, Rosenblum ND.
    Dev Biol; 2001 Mar 01; 231(1):31-46. PubMed ID: 11180950
    [Abstract] [Full Text] [Related]

  • 3. TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population.
    Oxburgh L, Chu GC, Michael SK, Robertson EJ.
    Development; 2004 Sep 01; 131(18):4593-605. PubMed ID: 15342483
    [Abstract] [Full Text] [Related]

  • 4. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis.
    Itman C, Loveland KL.
    Dev Dyn; 2008 Jan 01; 237(1):97-111. PubMed ID: 18069690
    [Abstract] [Full Text] [Related]

  • 5. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC, Li Y, Seghatoleslami MR, Dealy CN, Kosher RA.
    Matrix Biol; 2006 Jan 01; 25(1):27-39. PubMed ID: 16226436
    [Abstract] [Full Text] [Related]

  • 6. Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis.
    Michos O, Gonçalves A, Lopez-Rios J, Tiecke E, Naillat F, Beier K, Galli A, Vainio S, Zeller R.
    Development; 2007 Jul 01; 134(13):2397-405. PubMed ID: 17522159
    [Abstract] [Full Text] [Related]

  • 7. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC.
    Gastroenterology; 2007 Oct 01; 133(4):1272-81. PubMed ID: 17919499
    [Abstract] [Full Text] [Related]

  • 8. BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies.
    Martinez G, Mishina Y, Bertram JF.
    Int J Dev Biol; 2002 Oct 01; 46(4):525-33. PubMed ID: 12141440
    [Abstract] [Full Text] [Related]

  • 9. Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney.
    Meyer TN, Schwesinger C, Bush KT, Stuart RO, Rose DW, Shah MM, Vaughn DA, Steer DL, Nigam SK.
    Dev Biol; 2004 Nov 01; 275(1):44-67. PubMed ID: 15464572
    [Abstract] [Full Text] [Related]

  • 10. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.
    Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487
    [Abstract] [Full Text] [Related]

  • 11. Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3.
    Dwivedi PP, Grose RH, Filmus J, Hii CS, Xian CJ, Anderson PJ, Powell BC.
    Bone; 2013 Aug 01; 55(2):367-76. PubMed ID: 23624389
    [Abstract] [Full Text] [Related]

  • 12. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
    Upton PD, Long L, Trembath RC, Morrell NW.
    Mol Pharmacol; 2008 Feb 01; 73(2):539-52. PubMed ID: 17989347
    [Abstract] [Full Text] [Related]

  • 13. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney.
    Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, Meyer TN, Schwesinger C, Bai X, Esko JD, Nigam SK.
    Dev Biol; 2004 Aug 15; 272(2):310-27. PubMed ID: 15282150
    [Abstract] [Full Text] [Related]

  • 14. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
    Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S.
    Dev Biol; 2000 Sep 01; 225(1):179-87. PubMed ID: 10964473
    [Abstract] [Full Text] [Related]

  • 15. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
    Qiao W, Li AG, Owens P, Xu X, Wang XJ, Deng CX.
    Oncogene; 2006 Jan 12; 25(2):207-17. PubMed ID: 16170355
    [Abstract] [Full Text] [Related]

  • 16. Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins.
    Monteiro RM, de Sousa Lopes SM, Korchynskyi O, ten Dijke P, Mummery CL.
    J Cell Sci; 2004 Sep 15; 117(Pt 20):4653-63. PubMed ID: 15331632
    [Abstract] [Full Text] [Related]

  • 17. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
    Viviano BL, Silverstein L, Pflederer C, Paine-Saunders S, Mills K, Saunders S.
    Dev Biol; 2005 Jun 01; 282(1):152-62. PubMed ID: 15936336
    [Abstract] [Full Text] [Related]

  • 18. Traf2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-E1 osteoblasts.
    Shimada K, Ikeda K, Ito K.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):775-9. PubMed ID: 19836350
    [Abstract] [Full Text] [Related]

  • 19. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.
    Int J Cancer; 2003 Feb 10; 103(4):455-65. PubMed ID: 12478660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.